What are INDmoney investors doing with Cohance Lifesciences shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
-21%
Searches for Cohance Lifesciences on INDmoney have decreased by 21% over the last 30 days.
Average holding period of indmoney investors
21 days
INDmoney investors hold Cohance Lifesciences shares for an average of 21 days.
Key Events for Cohance Lifesciences
Cohance Lifesciences Stock Performance
as on November 19, 2026 at 9:31 pm IST
Day's Low
Day's High
₹451.05₹460.00
1.83%
Downside
0.12%
Upside

52 Week's Low
52 Week's High
₹266.70₹624.00
41.95%
Downside
35.81%
Upside

Cohance Lifesciences share price movements today
- Previous Close
- ₹456.40
- Open
- ₹458.00
- Volume
- 2.47L
- Upper Circuit
- ₹547.65
- Lower Circuit
- ₹365.15
- Day's Low - High
- ₹451.05 - ₹460.00
- 52 Week Low - High
- ₹266.70 - ₹624.00
Cohance Lifesciences Historical Returns
- 1 Month Return
- -0.28 %
- 3 Month Return
- + 2.14 %
- 1 Year Return
- -21.61 %
- 3 Year Return
- -23.09 %
- 5 Year Return
- -7.95 %
Cohance Lifesciences Fundamentals
as on November 19, 2026 at 4:01 pm IST
Market Cap
₹17,462.91 Cr
Return on Equity (ROE)
5.23
PE Ratio (TTM)
368.06
Return on capital employed (ROCE)
7.31
Industry PE ratio
53.92
Beta (LTM)
0.8
P/B Ratio
2.58
Dividend Yield
0PEG Ratio
-40.18
Quarterly Earnings Growth YOY
-96.58
EPS (TTM)
3.92
Book Value
102.23
Cohance Lifesciences Stock Valuation
as on November 19, 2026 at 4:01 pm IST
Cohance Lifesciences in the last 5 years
Lowest (4.48x)
March 30, 2020
Industry (53.92x)
November 18, 2026
Today (368.06x)
November 18, 2026
Highest (388.19x)
October 29, 2026
Today’s Price to Earnings Ratio: 368.06x
Cohance Lifesciences Technical Analysis
Track how Cohance Lifesciences technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0.42 | |
CCI (20) | -439.3 | Bullish |
RSI (14) | 60.02 | Neutral |
Momentum (10) | 0.8 | Bullish |
ADI (14) | 17.76 | Neutral |
Ultimate Oscillator (7,14,28) | 82.9 | Bullish |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 459.33 | Bullish |
EMA (20) | 459.19 | Bullish |
VWMA (20) | 459.4 | Bullish |
SMA (50) | 457.65 | Bullish |
EMA (50) | 458.13 | Bullish |
SMA (200) | 455.96 | Bullish |
EMA (200) | 456.47 | Bullish |
KAMA (200) | 457.79 | Bullish |
DEMA (200) | 457.25 | Bullish |
Cohance Lifesciences Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Cohance Lifesciences with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 17,462.91 | -1.59% | 0.62 | 150 | 2,268 | |
| BUY | 14,872.25 | 11.22% | 0.73 | 397 | 8,279 | |
| NA | 6,169.80 | -4.62% | 0.66 | 1,553 | 1,879 | |
| BUY | 12,777.08 | 35.89% | 0.68 | 281 | 1,703 | |
| BUY | 16,770.25 | 16.06% | 0.57 | 320 | 1,875 |
Market expectation of Cohance Lifesciences Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
37.50%
Buy
12.50%
Hold
50.00%
Sell
Cohance Lifesciences Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Cohance Lifesciences Ltd Annual Profit & Loss
Figures in Rupees Crores
Cohance Lifesciences Ltd Cash Flow
Figures in Rupees Crores
Mutual Funds Buying / Exiting Cohance Lifesciences
Holdings as of 15 Nov 2026 · based on the latest SEBI-mandated portfolio disclosures
Mutual Funds Buying Cohance Lifesciences
Sorted by largest increase in holding, month-over-month.
No buying activity data available right now
Mutual Funds Exiting Cohance Lifesciences
Sorted by largest decrease in holding, month-over-month.
Fund Name | Value of Holding | Decrease (MoM) | Holding % |
|---|---|---|---|
ICICI Prudential Healthcare Fund Direct Growth | ₹269.55 Cr | ₹17.76 Cr (-6.18%) | 3.67% |
Cohance Lifesciences Corporate Actions
View detailed summary of the earnings and dividend history of Cohance Lifesciences.
Cohance Lifesciences Ltd Earnings Results
Cohance Lifesciences Ltd’s net profit fell -79.45% since last year same period to ₹15.22Cr in the Q2 2026-2027. On a quarterly growth basis, Cohance Lifesciences Ltd has generated 163.1% jump in its net profits since last 3-months.
Read MoreCohance Lifesciences Ltd Dividends September,2022
In the quarter ending June 2022, Cohance Lifesciences Ltd has declared dividend of ₹5.00 per share on 02 Sep 2022 - translating a dividend yield of 2.44%.
Read More about Dividends
Indices Featuring Cohance Lifesciences Stock
Check stock indices that include Cohance Lifesciences.
Insights on Cohance Lifesciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 2 quarters, 434.51 Cr → 489.06 Cr (in ₹), with an average increase of 11.2% per quarter
POSITIVE IMPACTRetail Holding Up

Retail Investor have increased holdings from 15.92% to 15.95% in Sep 2026 quarter
POSITIVE IMPACTFII Holding Up

Foreign Institutions have increased holdings from 6.50% to 7.71% in Sep 2026 quarter
POSITIVE IMPACTProfit Spike

Netprofit is up for the last 2 quarters, -24.12 Cr → 15.22 Cr (in ₹), with an average increase of 258.5% per quarter
NO EFFECTAgainst Peers

In the last 3 years, Laurus Labs Ltd has given 531.0% return, outperforming this stock by 554.1%
NO EFFECTAgainst Peers

In the last 1 year, Laurus Labs Ltd has given 135.2% return, outperforming this stock by 156.8%
NEGATIVE IMPACTPrice Dip

In the last 7 days, COHANCE stock has moved down by -3.2%
NEGATIVE IMPACTMF Holding Down

Mutual Funds have decreased holdings from 18.21% to 16.93% in Sep 2026 quarter
NEGATIVE IMPACTPromoter Holding Down

Promoters have decreased holdings from 57.49% to 57.48% in Sep 2026 quarter
About Cohance Lifesciences Ltd
Revenue: ₹476.65Cr as on September 2026 (Q2 FY27)
Net Profit: ₹2.27Cr as on September 2026 (Q2 FY27)
Listing date: 05 Mar, 2020
Chairperson Name: Annaswamy Vaidheesh
| Organisation | Cohance Lifesciences Ltd |
| Industry | Pharmaceuticals |
| CEO | Annaswamy Vaidheesh |
| E-voting on shares | Click here to vote |
FAQs
What is Cohance Lifesciences share price today?
Cohance Lifesciences share price today stands at ₹459.45 as on at the close of the market. Cohance Lifesciences share today touched a day high of ₹460 and a low of ₹451.05.
What is the 52 week high and 52 week low range for Cohance Lifesciences share?
Cohance Lifesciences touched a 52 week high of ₹624 and a 52 week low of ₹266.7. Cohance Lifesciences share price today i.e. is closed at ₹459.45, which is -26.37% down from its 52 week high and 72.27% up from its 52 week low.
What is Cohance Lifesciences's market capitalisation today?
Cohance Lifesciences market capitalisation is ₹17,462.91 Cr as on .
How to buy Cohance Lifesciences shares?
To buy Cohance Lifesciences shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for COHANCE or Cohance Lifesciences Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Cohance Lifesciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Cohance Lifesciences trading volume today?
Cohance Lifesciences trading volume is 2.47L as on . This means that 2.47L shares of Cohance Lifesciences were bought and sold on the stock market during today's trading session.